We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Robot-Assisted PCR Among Innovations Driving qPCR Sector

By LabMedica International staff writers
Posted on 21 Dec 2014
Print article
Seeking efficiency in the qPCR process, a number of automation and robotics technologies have been added to product offerings from top competitors. According to the new Kalorama Information (New York, NY, USA) report “qPCR and dPCR Markets: Clinical and Research Markets,” this is one factor driving the usefulness of this workhorse lab technology.

The Kalorama report on quantitative-PCR (qPCR) and digital-PCR (dPCR) specifies relevant markets for in vitro diagnostics (IVD) applications and for general research of diseases and new drug development. It also lists companies that currently provide robot qPCR services. The total qPCR market is valued at about USD 3.2 billion for 2013, up from USD 2.8 billion in 2011, an increase of 5.9%.

Robots can provide the precision needed to run smaller reactions, which can reduce cost by stretching reagents and samples much further, by 25%–50%. Robots also can save time, typically requiring less time to prepare reactions. Robots used for qPCR are generally small in size, single-channel, with at least 6 separate spaces on the deck. A hood over the surface helps minimize contamination. Software is critical to the functioning of the qPCR robot.

"Robots bring speed and precision to PCR," said Mary Anne Crandall, Kalorama analyst and author of the report, "These, in turn, are expected to bring cost savings. Because of the advantages of robotics in qPCR, it is anticipated that the market will become increasingly automated and robots will become standard in the qPCR laboratory."

Most modernized laboratories either possess a qPCR instrument or have access to one. Many laboratories produce a huge number of reactions daily, and require skilled personnel to set up and run the operations. Because there are differences between operators and between laboratories, there can be significant differences in pipetting of samples, which can translate into questionable reproducibility. Robots can provide the precision necessary to address these issues.

Related Links:

Kalorama Information
qPCR and dPCR: Research and Clinical Markets, report


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Ultrasound-based duplex sonography combined with a new genetic testing procedure can identify clonal haematopoiesis (Photo courtesy of 123RF)

New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk

A key interest area in cardiovascular research today is the impact of clonal hematopoiesis on cardiovascular diseases. Clonal hematopoiesis results from mutations in hematopoietic stem cells and may lead... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.